Biolase Net Worth 2010-2023 | BIOL

Interactive chart of historical net worth (market cap) for Biolase (BIOL) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Biolase net worth as of April 25, 2024 is $0B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.005B $0.049B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $70.953B 18.99
Becton Dickinson (BDX) United States $66.586B 19.34
West Pharmaceutical Services (WST) United States $26.953B 48.06
Cardinal Health (CAH) United States $25.250B 15.18
Align Technology (ALGN) United States $23.366B 45.13
Cooper (COO) United States $17.874B 27.05
Labcorp (LH) United States $16.686B 14.39
Henry Schein (HSIC) United States $9.356B 16.18
DENTSPLY SIRONA (XRAY) United States $6.293B 16.58
Merit Medical Systems (MMSI) United States $4.261B 24.38
Patterson (PDCO) United States $2.311B 11.07
STAAR Surgical (STAA) United States $2.304B 72.14
CONMED (CNMD) United States $1.906B 17.29
Atrion (ATRI) United States $0.702B 36.17
Lifevantage (LFVN) United States $0.080B 13.00
Pro-Dex (PDEX) United States $0.065B 24.61